OTC Pharmaceuticals - Indonesia

Indonesia

Revenue in the OTC Pharmaceuticals market amounts to €2,784.00m in 2024. The market is expected to grow annually by 8.17% (CAGR 2024-2029).
The market's largest segment is the segment Vitamins & Minerals with a market volume of €689.60m in 2024.
In global comparison, most revenue is generated in the United States (€38,250m in 2024).
In relation to total population figures, per person revenues of €9.95 are generated in 2024.
In the OTC Pharmaceuticals market, 27.1% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The OTC Pharmaceuticals market in Indonesia has been experiencing steady growth in recent years.

Customer preferences: Indonesian consumers have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the convenience and accessibility of OTC products compared to prescription medications. Customers appreciate the ability to self-diagnose and self-treat minor ailments without the need for a doctor's visit. Additionally, OTC products are often more affordable than prescription medications, making them an attractive option for cost-conscious consumers.

Trends in the market: One of the key trends in the OTC Pharmaceuticals market in Indonesia is the increasing demand for herbal and traditional medicines. Indonesian consumers have a long-standing tradition of using natural remedies for various health issues, and this trend has translated into the OTC market. Products made from traditional Indonesian herbs and plants are gaining popularity as consumers seek out natural alternatives to synthetic medications. This trend is expected to continue as consumers become more health-conscious and seek out products with fewer side effects. Another trend in the market is the growing popularity of online sales channels. With the increasing penetration of smartphones and internet access in Indonesia, more consumers are turning to e-commerce platforms to purchase OTC pharmaceutical products. Online sales offer convenience, a wide range of product options, and often competitive pricing. This shift towards online sales has prompted many companies to invest in digital marketing strategies and improve their online presence to capture this growing customer segment.

Local special circumstances: Indonesia is a vast archipelago with a diverse population spread across thousands of islands. This geographical challenge presents unique distribution and logistics issues for the OTC Pharmaceuticals market. Companies need to establish an extensive distribution network to reach consumers in remote areas, which can be costly and time-consuming. Furthermore, cultural and linguistic diversity across the country necessitates localized marketing strategies to effectively communicate with consumers.

Underlying macroeconomic factors: The development of the OTC Pharmaceuticals market in Indonesia is closely tied to the country's macroeconomic factors. Indonesia has experienced steady economic growth in recent years, leading to an expansion of the middle class and increased disposable income. As a result, consumers have more purchasing power to spend on healthcare products, including OTC pharmaceuticals. Additionally, the government's efforts to improve healthcare infrastructure and increase access to healthcare services have also contributed to the growth of the OTC Pharmaceuticals market. In conclusion, the OTC Pharmaceuticals market in Indonesia is growing due to customer preferences for convenience, affordability, and natural remedies. The market is also being influenced by trends such as the increasing popularity of herbal and traditional medicines and the rise of online sales channels. However, companies operating in Indonesia need to navigate unique challenges posed by the country's geographical diversity and cultural differences. The market's growth is underpinned by favorable macroeconomic factors, including steady economic growth and government initiatives to improve healthcare access.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.